Huadong Medicine Co., Ltd.: Obesity trials
The registry lists 13 Obesity studies with Huadong Medicine Co., Ltd. as lead sponsor. 10 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 3Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07794397Phase 3
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07787260Phase 3
- A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNot yet recruitingNCT07559240Phase 1
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesRecruitingNCT07521631Phase 2
- Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingNCT07502001Phase 1
- Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesRecruitingNCT07279194Phase 3
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese PatientsRecruitingNCT07036172Phase 3
- Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes MellitusRecruitingNCT06886126Phase 2
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNot yet recruitingNCT06885021Phase 3
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNot yet recruitingNCT06500299Phase 2
- A Pharmacokinetic Study of HDM1005 Injection at Different Injection SitesActive, not recruitingNCT07828197Phase 1
- Phase Ia Clinical Study of HDM1005 InjectionCompletedNCT06640647Phase 1
- Phase Ib Clinical Study of HDM1005 InjectionCompletedNCT06637020Phase 1